Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Disease-modifying anti-rheumatic drugs (DMARDs) help to slow the progress of RA by decreasing the body's overactive immune response
Key Takeaways CJC-1295 plus Ipamorelin is not FDA approved: There is no approved CJC-1295/Ipamorelin brand, finished drug, or human therapeutic indication
& Repa, J
The primary component is sterile water, but the differentiator is the additive: benzyl alcohol , present at a concentration of 0.9%
Track these metrics weekly at minimum: body weight (same time, same conditions, preferably morning before eating), waist circumference, how you feel subjectively (energy, hunger, mood), any side effects and their severity, and your injection details (date, time, dose, site)
Manufactured in an FDA Registered Facility using Good Manufacturing Practices (GMPs) *This statement has not been evaluated by the Food and Drug Administration